M42 CEO Dimitris Moulavasilis on AI, genomics, preventive healthcare and global expansion

AI-generated atlas summary

Why this is in the atlas

CNBC says M42 CEO Dimitris Moulavasilis discussed how the healthcare company is combining AI, genomics, and clinical services to reshape healthcare. The source description also mentions the Emirati Genome Programme and the group’s international expansion. For people learning about AI in healthcare, this matters because it points to practical uses of AI in prevention, research, and service delivery, not just in hospital administration or medical imaging.

Generated from the article title and available source metadata. Verify details with the original publisher.

• healthcare